CORC  > 南华大学
Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: A meta-Analysis
Liu, Yangzhou; Zhao, Shankun; Wang, Jiamin; Zhu, Zhiguo; Luo, Lianmin; Li, Ermao; Tang, Fucai; Zhao, Zhigang*
刊名UROLOGIA INTERNATIONALIS
2019
卷号102期号:4页码:373-384
关键词Castration-resistant prostate cancer Chromogranin A Neurone-specific enolase Neuroendocrine Meta-analysis
ISSN号0042-1138
DOI10.1159/000495512
URL标识查看原文
WOS记录号WOS:000470862400001
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5695598
专题南华大学
作者单位1.[Wang, Jiamin
2.Liu, Yangzhou
3.Zhao, Shankun
4.Luo, Lianmin
5.Zhao, Zhigang
6.Zhu, Zhiguo
7.Tang, Fucai] Guangzhou Med Univ, Guangdong Prov Key Lab Urol, Dept Urol & Androl, Minimally Invas Surg Ctr,Affiliated Hosp 2, Guangzhou 510230, Guangdong, Peoples R China.
推荐引用方式
GB/T 7714
Liu, Yangzhou,Zhao, Shankun,Wang, Jiamin,et al. Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: A meta-Analysis[J]. UROLOGIA INTERNATIONALIS,2019,102(4):373-384.
APA Liu, Yangzhou.,Zhao, Shankun.,Wang, Jiamin.,Zhu, Zhiguo.,Luo, Lianmin.,...&Zhao, Zhigang*.(2019).Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: A meta-Analysis.UROLOGIA INTERNATIONALIS,102(4),373-384.
MLA Liu, Yangzhou,et al."Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: A meta-Analysis".UROLOGIA INTERNATIONALIS 102.4(2019):373-384.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace